Revised American Thyroid Association guidelines for the management of medullary thyroid carcinoma. Thyroid 2015 Jun;25(6):567-610
Date
03/27/2015Pubmed ID
25810047Pubmed Central ID
PMC4490627DOI
10.1089/thy.2014.0335Scopus ID
2-s2.0-84930511149 (requires institutional sign-in at Scopus site) 1492 CitationsAbstract
INTRODUCTION: The American Thyroid Association appointed a Task Force of experts to revise the original Medullary Thyroid Carcinoma: Management Guidelines of the American Thyroid Association.
METHODS: The Task Force identified relevant articles using a systematic PubMed search, supplemented with additional published materials, and then created evidence-based recommendations, which were set in categories using criteria adapted from the United States Preventive Services Task Force Agency for Healthcare Research and Quality. The original guidelines provided abundant source material and an excellent organizational structure that served as the basis for the current revised document.
RESULTS: The revised guidelines are focused primarily on the diagnosis and treatment of patients with sporadic medullary thyroid carcinoma (MTC) and hereditary MTC.
CONCLUSIONS: The Task Force developed 67 evidence-based recommendations to assist clinicians in the care of patients with MTC. The Task Force considers the recommendations to represent current, rational, and optimal medical practice.
Author List
Wells SA Jr, Asa SL, Dralle H, Elisei R, Evans DB, Gagel RF, Lee N, Machens A, Moley JF, Pacini F, Raue F, Frank-Raue K, Robinson B, Rosenthal MS, Santoro M, Schlumberger M, Shah M, Waguespack SG, American Thyroid Association Guidelines Task Force on Medullary Thyroid CarcinomaAuthor
Douglas B. Evans MD Chair, Professor in the Surgery department at Medical College of WisconsinMESH terms used to index this publication - Major topics in bold
Antineoplastic Combined Chemotherapy ProtocolsBiopsy, Fine-Needle
Carcinoma, Medullary
Carcinoma, Neuroendocrine
Disease Management
Genetic Testing
Hormone Replacement Therapy
Humans
Multiple Endocrine Neoplasia Type 2a
Multiple Endocrine Neoplasia Type 2b
Proto-Oncogene Proteins c-ret
Radiotherapy
Societies, Medical
Thyroid Neoplasms
Thyroidectomy